| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 08/01/2013 | US20130196993 N-heteroaryl compounds |
| 08/01/2013 | US20130196992 1',3'-disubstituted-4-pheny-3,4,5,6-tetrahydro-2h,1'h-[1,4']bipyridinyl-2'-ones |
| 08/01/2013 | US20130196987 Macrocyclic compounds useful as pharmaceuticals |
| 08/01/2013 | US20130196978 Alkaloid aminoester derivatives and medicinal composition thereof |
| 08/01/2013 | US20130196973 Benzodioxane inhibitors of leukotriene production |
| 08/01/2013 | CA2862535A1 Substituted pyrano and furanoquinolines, their preparation and use as medicaments |
| 08/01/2013 | CA2858105A1 Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them |
| 08/01/2013 | CA2857969A1 (1r,4r) 7-oxo-2-azabicyclo[2.2.2]oct-5-ene and derivatives thereof |
| 07/31/2013 | EP2620438A1 Substituted pyrano and furanoquinolines, their preparation and use as medicaments |
| 07/31/2013 | CN103228661A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 07/31/2013 | CN103228647A Materials for organic electroluminescent devices |
| 07/31/2013 | CN103224500A Annular secondary amino substitution cryptolepine ramification and preparation method thereof and application of annular substitution cryptolepine ramification being used as anti-cancer drug |
| 07/31/2013 | CN102190661B Tricyclic benzopyran compound as anti-arrhythmic agents |
| 07/31/2013 | CN101516889B Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones |
| 07/31/2013 | CN101460462B Spirocyclic nitriles as protease inhibitors |
| 07/25/2013 | WO2013109739A1 Tricyclic sulfonamide compounds and methods of making and using same |
| 07/25/2013 | WO2013109521A1 Pyran-spirocyclic piperidine amides as modulators of ion channels |
| 07/25/2013 | WO2013109045A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 07/25/2013 | WO2013108921A1 Industrial process for preparation of 1,2-dihydroquinoline derivative or a salt thereof, and intermediate for preparation thereof |
| 07/25/2013 | WO2013108754A1 Pyrazine carboxamide compound |
| 07/25/2013 | WO2013108227A1 Heterocyclic amide derivatives as p2x7 receptor antagonists |
| 07/25/2013 | WO2013107743A1 Spiroindoline derivatives as gonadotropin- releasing hormone receptor antagonists |
| 07/25/2013 | WO2013107428A1 7-substituted hanfangichin b derivative, and preparation method and use thereof |
| 07/25/2013 | US20130190488 Apoptosis promoters |
| 07/25/2013 | US20130190292 Heterocyclyl pyrazolopyrimidine analogues as selective jak inhibitors |
| 07/25/2013 | US20130190288 Benzyl sulfonamide derivatives as rorc modulators |
| 07/25/2013 | CA2863343A1 Pyran-spirocyclic piperidine amides as modulators of ion channels |
| 07/25/2013 | CA2863228A1 Heterocyclic amide derivatives as p2x7 receptor antagonists |
| 07/25/2013 | CA2861390A1 Tricyclic sulfonamide compounds and methods of making and using same |
| 07/24/2013 | EP2618394A1 Organic electroluminescent element |
| 07/24/2013 | EP2617724A1 Nitrogenated aromatic compound, organic semiconductor material, and organic electronic device |
| 07/24/2013 | EP2617419A1 Aza spiro alkane derivatives as inhibitors of metallproteases |
| 07/24/2013 | EP2616465A1 Triazine-oxadiazoles |
| 07/24/2013 | EP2616460A1 Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine. |
| 07/24/2013 | CN103221408A Triazine-oxadiazoles |
| 07/24/2013 | CN103221404A Nitrogen heterocyclic compounds useful as PDE10 inhibitors |
| 07/24/2013 | CN103221402A Triazole derivatives and their use for neurological disorders |
| 07/24/2013 | CN103217504A Preparation method of Cr<3+> color indicator based on rhodamine B-diethylene triamine derivative |
| 07/24/2013 | CN103214494A Acid-sensitive double light emission probe, preparation method and uses thereof |
| 07/24/2013 | CN103214493A Method for generating narcotine by selective reduction utilizing chiral boron catalyst |
| 07/24/2013 | CN102112439B 5-heterocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enones as herbicides |
| 07/24/2013 | CN101851242B Preparation method of asenapine intermediate |
| 07/24/2013 | CN101613386B Gambogic acid cyclized analog, preparation method and application thereof |
| 07/23/2013 | US8492547 Method for the enrichment of buprenorphine using chromatographic techniques |
| 07/23/2013 | CA2585089C Fused pyrimidines and their use as inhibitors of pi3k |
| 07/18/2013 | WO2013105206A1 Material for organic electroluminescent element, and element using same |
| 07/18/2013 | US20130184305 Process for preparation of novel 42-o-(heteroalkoxyalkyl) rapamicin compounds with anti-proliferative properties |
| 07/18/2013 | US20130184297 Quinazoline derivatives substituted by aniline, preparation method and use thereof |
| 07/18/2013 | US20130184253 Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as c5a receptor modulators |
| 07/18/2013 | US20130184250 Therapeutic Agents |
| 07/18/2013 | US20130184240 Hetero ring-fused imidazole derivative having ampk activating effect |
| 07/18/2013 | US20130183388 Novel IDO Inhibitors and Methods of Use Thereof |
| 07/18/2013 | US20130183269 Hepatitis C Virus Inhibitors |
| 07/17/2013 | EP2615092A1 Heterocyclic amino berbamine derivatives, preparation method and use thereof |
| 07/17/2013 | EP2613782A2 Indazole derivatives useful as erk inhibitors |
| 07/17/2013 | CN103204860A Amaryllidaceae alkaloids compound with neuroprotective effect |
| 07/17/2013 | CN103204846A Carbazole derivative, organic electroluminescent device thereof, and manufacturing method of device |
| 07/17/2013 | CN101821253B Piperidine derivative |
| 07/17/2013 | CN101460502B Bicyclic enamino(thio)carbonyl compounds |
| 07/17/2013 | CN101248050B Organic compounds |
| 07/17/2013 | CN101203495B Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase MET |
| 07/16/2013 | US8486989 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 07/16/2013 | US8486966 9-(pyrazol-3-yl)-9H-purine-2-amine and 3-(pyrazol-3-yl) -3H-imidazo[4,5-B] pyridin-5-amine derivatives and their use for the treatment of cancer |
| 07/16/2013 | US8486952 Compounds for the reduction of β-amyloid production |
| 07/16/2013 | US8486901 Sodium channel blocking compounds tetrodotoxin galactopyranosides |
| 07/16/2013 | US8486708 Perylene nanofiber fluorescent sensor for highly sensitive and selective sensing of amines |
| 07/11/2013 | WO2013103738A1 Napthalene acetic acid derivatives against hiv infection |
| 07/11/2013 | WO2013103724A1 2- (tert - butoxy) -2- (7 -methylquinolin- 6 - yl) acetic acid derivatives for treating aids |
| 07/11/2013 | WO2013102992A1 Material for organic electroluminescence element and element using same |
| 07/11/2013 | WO2013102655A1 4,4-disubstituted-1,4-dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis b |
| 07/11/2013 | US20130178494 Phenyl n-mustard linked to dna-affinic molecules or water-soluble aryl rings, method and their use as cancer therapeutic agents |
| 07/11/2013 | US20130178470 Heterocyclic aminoberbamine derivatives, the preparation process and use thereof |
| 07/11/2013 | US20130178462 Compounds for the reduction of beta-amyloid production |
| 07/11/2013 | US20130178457 Cannabinoid receptor modulators |
| 07/11/2013 | US20130178456 Arylethynyl derivatives |
| 07/11/2013 | US20130178453 Cannabinoid Agonists |
| 07/11/2013 | US20130177530 Antiviral compounds |
| 07/11/2013 | US20130177529 Pyrazole Compounds |
| 07/10/2013 | EP2611804A1 Novel compounds and compositions for the inhibition of nampt |
| 07/10/2013 | CN103201273A Novel compounds for organic electronic material and organic electroluminescent device using the same |
| 07/10/2013 | CN103193788A Lycorine alkaline compound with neuroprotective effect |
| 07/10/2013 | CN103193787A Lycoris alkali compound having neuroprotective effect and preparation method thereof |
| 07/10/2013 | CN103193697A Light-emitting device material and light-emitting device |
| 07/10/2013 | CN102850363B Irinotecan hydrochloride compound and pharmaceutical composition thereof |
| 07/10/2013 | CN101981038B Dioxolane and dioxolanone fused indolobenzadiazepine HCV NS5B inhibitors |
| 07/10/2013 | CN101932585B Substituted spirocyclic piperidine derivatives as histamine-3 (h3) receptor ligands |
| 07/09/2013 | US8481737 Solid forms of a chemokine receptor antagonist and methods of use thereof |
| 07/09/2013 | US8481555 Aza-bicyclic amine N-oxide compounds as alpha-7 nicotinic acetylcholine receptor ligand pro-drugs |
| 07/04/2013 | WO2013098320A1 Quinazolinone derivatives as hcv inhibitors |
| 07/04/2013 | WO2013098313A1 Hetero-bicyclic derivatives as hcv inhibitors |
| 07/04/2013 | WO2013097226A1 Fused tetra or penta-cyclic pyridophthalazinones as parp inhibitors |
| 07/04/2013 | US20130172550 P2x4 receptor antagonist |
| 07/04/2013 | US20130172549 Heteroaryl amide derivatives |
| 07/04/2013 | US20130172372 Ring-fused 4-aminopyrimidines and use thereof as stimulators of soluable guanylate cyclases |
| 07/04/2013 | US20130172343 Derivatives of 1H-isoindol-3-amine, 1H-iso-aza-indol-3amine, 3,4-dihydroisoquinolin-1-amine, and 1,4-dihydroisoquinolin-3-amine as Beta-secretase Inhibitors |
| 07/04/2013 | US20130172336 4-anilinofuro[2,3-b]quinoline derivatives, their preparation processes, and pharmaceutical compositions comprising the same |
| 07/04/2013 | US20130172334 Trpv1 antagonists |
| 07/04/2013 | US20130171715 Phenyl Xanthene Dyes |
| 07/03/2013 | EP2610257A1 Diimidated derivative of berbamine, and preparation method therefor and use thereof |
| 07/03/2013 | EP2610247A1 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-HT6 antagonists |